Histogen Inc.
DelistedCIK 1383701fmd_01DT6EBRZ4ZPTAY3FW917WG84FManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2007 to Sep 30, 2023, 52 periods
Latest annual · FY2022
Millions- Total revenues
- 4
- Operating income
- (11)
- Net income
- (11)
- Free cash flow
- (10)
Latest quarter · Q3 FY2023
Millions- Total revenues
- 0
- Operating income
- (4)
- Net income
- (4)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- -44.2%
- Revenue, 5 yearsFY2017 to FY2022
- -36.1%
- Net income, 5 yearsFY2017 to FY2022
- n/m
Histogen Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $3.8 million | $1 million | +265.2% | 10-K 2023-03-09 · proof |
| Operating income | -$10.6 million | -$15.5 million | 10-K 2023-03-09 · proof | |
| Net income | -$10.6 million | -$15 million | 10-K 2023-03-09 · proof | |
| Cash from operating activities | -$9.7 million | -$14.5 million | 10-K 2023-03-09 · proof | |
| Free cash flow | -$9.9 million | -$14.8 million | 10-K 2023-03-09 · proof | |
| Total assets | $19.1 million | $27.2 million | -30% | 10-K 2023-03-09 · proof |
| Total liabilities | $5.7 million | $7.1 million | -19.3% | 10-K 2023-03-09 · proof |
| Cash and cash equivalents | $12.1 million | $18.7 million | -35.2% | 10-K 2023-03-09 · proof |
- What was Histogen Inc.'s revenue in fiscal 2022?
- Histogen Inc. reported revenue of $3.8 million for fiscal 2022 (the year ended Dec 31, 2022), against $1 million the year before (+265.2%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Histogen Inc.'s operating income in fiscal 2022?
- Histogen Inc. reported operating income of -$10.6 million for fiscal 2022 (the year ended Dec 31, 2022), against -$15.5 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Histogen Inc.'s net income in fiscal 2022?
- Histogen Inc. reported net income of -$10.6 million for fiscal 2022 (the year ended Dec 31, 2022), against -$15 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Histogen Inc.'s cash from operating activities in fiscal 2022?
- Histogen Inc. reported cash from operating activities of -$9.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$14.5 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was Histogen Inc.'s free cash flow in fiscal 2022?
- Histogen Inc. reported free cash flow of -$9.9 million for fiscal 2022 (the year ended Dec 31, 2022), against -$14.8 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are Histogen Inc.'s total assets?
- As of Dec 31, 2022, Histogen Inc. reported total assets of $19.1 million, against $27.2 million a year earlier (-30%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are Histogen Inc.'s total liabilities?
- As of Dec 31, 2022, Histogen Inc. reported total liabilities of $5.7 million, against $7.1 million a year earlier (-19.3%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are Histogen Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Histogen Inc. reported cash and cash equivalents of $12.1 million, against $18.7 million a year earlier (-35.2%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1383701&period_type=annual&limit=5"Information only, not investment advice.